Trending/Biogen Alzheimer's drug
FDA approves aducanumab to treat Alzheimer’s disease
The Food and Drug Administration (FDA) approved aducanumab to treat Alzheimer's disease on Monday, June 7. About 6 million people in the U.S. and 30…
No information found.
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community